ICICI Venture

ICICI Venture's historical portfolio spans pharmaceuticals, healthcare delivery, industrial manufacturing, financial services, and consumer retail. Notable exits include stakes in Aurobindo Pharma, VA Tech Wabag, and Go Airlines (prior to its restructuring). The firm's real estate arm has developed significant residential and commercial projects across Mumbai, Bengaluru, and Chennai. In recent vintages, the firm has increased its exposure to enterprise technology and specialty chemicals alongside its legacy industrial and pharma positions.

ICICI Venture primarily raises capital from domestic Indian limited partners, including ICICI Group entities, Indian insurance companies, and family offices. While its earliest funds had multilateral development-finance backing through its IFC and World Bank relationships, the firm's recent India Advantage Fund vintages have been predominantly India-raised. The firm does not currently market a separate offshore vehicle, distinguishing it from India-focused GPs that maintain both domestic and Mauritius- or Singapore-domiciled funds.

ICICI Venture's parentage provides a sourcing advantage few Indian mid-market GPs can replicate. ICICI Bank's corporate-banking relationships give the firm early visibility into succession-driven sale processes, stressed-asset auctions, and growth-equity rounds at portfolio companies of the bank. The firm's investment team also originates proprietary transactions through the promoter networks built over three decades of mid-market Indian investing. This dual origination model — proprietary bank-intelligence funnel plus long-tenure GP relationships — means ICICI Venture frequently participates in transactions before broader auction processes launch.

ICICI Venture's leadership has historically been drawn from senior ICICI Bank executives. The firm's president and executive director roles have been held by career ICICI Group leaders with significant Indian corporate-finance and restructuring experience. The investment team is organized by strategy vertical — private equity, real estate, and special situations — each with a managing director reporting to the firm's investment committee. As of the latest public records, the firm has not disclosed a change in its top leadership structure.